Boston Business Journal -- Inverness Medical Innovations Inc., a developer of medical technologies for the consumer market, has closed its $240 million acquisition of Concateno plc, a London-based provider of drug-testing services.
Boston Business Journal -- Inverness Medical Innovations Inc., a developer of medical technologies for the consumer market, has closed its $240 million acquisition of Concateno plc, a London-based provider of drug-testing services.
